Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Lung Cancer |
Free Subscription
1 Am J Ind Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Mortality of older construction and craft workers employed at Department of
Energy (DOE) nuclear sites: Follow-up through 2021.
Am J Ind Med. 2024;67:261-273.
PubMed
Abstract available
Lymphangioleiomyomatosis: No Longer Ultra-rare.
Am J Respir Crit Care Med. 2024;209:358-359.
PubMed
Updated Prevalence of Lymphangioleiomyomatosis in Europe.
Am J Respir Crit Care Med. 2024;209:456-459.
PubMed
Pulmonary rehabilitation improves exercise capacity, health-related quality of
life, and cardiopulmonary function in patients with non-small cell lung cancer.
BMC Cancer. 2024;24:211.
PubMed
Abstract available
Molecular alterations and clinical prognostic factors in resectable non-small
cell lung cancer.
BMC Cancer. 2024;24:200.
PubMed
Abstract available
Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in
EGFR-mutant non-small cell lung cancer patients.
BMC Cancer. 2024;24:197.
PubMed
Abstract available
Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence
during 2014-2017.
BMC Cancer. 2024;24:191.
PubMed
Abstract available
Comparison of partitioned survival modeling with state transition modeling
approaches with or without consideration of brain metastasis: a case study of
Osimertinib versus pemetrexed-platinum.
BMC Cancer. 2024;24:189.
PubMed
Abstract available
Correction: Targeting serine/glycine metabolism improves radiotherapy response in
non-small cell lung cancer.
Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-024-02603.
PubMed
Phase 3 AEGEAN trial results show the benefit of perioperative
immunotherapy-based treatment for NSCLC.
Cancer. 2024;130:495-496.
PubMed
A local perspective on internal, external, and reflexive biomarker testing
processes for lung cancer in an academic medical center.
Cancer. 2024 Feb 14. doi: 10.1002/cncr.35240.
PubMed
Cumulative incidence and risk factors of brain metastases in metastatic non-small
cell lung cancer without baseline brain metastasis: Pooled analysis of
individualized patient data from IMpower130, IMpower131, and IMpower150.
Cancer. 2024 Feb 14. doi: 10.1002/cncr.35242.
PubMed
Abstract available
Examining crossover and postprotocol therapies in first-line immunotherapy trials
in non-small cell lung cancer (NSCLC).
Cancer. 2024 Feb 14. doi: 10.1002/cncr.35250.
PubMed
Abstract available
Updated American Cancer Society lung cancer screening guidelines: The new
guidelines offer expanded criteria recommended for lung cancer screening based on
age, smoking status, and smoking history.
Cancer. 2024;130:656-657.
PubMed
Re-inventing a better wheel? Serplulimab for squamous cell lung cancer.
Cancer Cell. 2024;42:172-174.
PubMed
Abstract available
Interferon-stimulated neutrophils as a predictor of immunotherapy response.
Cancer Cell. 2024;42:253-265.
PubMed
Abstract available
The intratumor mycobiome promotes lung cancer progression via myeloid-derived
suppressor cells.
Cancer Cell. 2024;42:318-322.
PubMed
Macrophages Under the Influence of Tumor Mesothelin Weaken Host Defenses against
Pancreatic Cancer Metastasis.
Cancer Res. 2024;84:513-514.
PubMed
Abstract available
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive
Cellular Contexts.
Cancer Res. 2024 Feb 15. doi: 10.1158/0008-5472.CAN-23-0438.
PubMed
Abstract available
Nationwide prospective registry database of patients with newly diagnosed
untreated pleural mesothelioma in Japan.
Cancer Sci. 2024;115:507-528.
PubMed
Abstract available
Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against
malignant mesothelioma by natural killer cells.
Cancer Sci. 2024;115:357-368.
PubMed
Abstract available
Effects of Sirolimus on Anti-SARS-CoV-2 Vaccination in Patients With
Lymphangioleiomyomatosis.
Chest. 2024;165:303-306.
PubMed
A PLUS Prediction Model Provides Insights Into the Probability of Mediastinal
Metastasis.
Chest. 2024;165:248-249.
PubMed
Impact of structured reporting for lung cancer screening low-dose CT scan
incidental findings on physician management.
Chest. 2024 Feb 10:S0012-3692(24)00147-8. doi: 10.1016/j.chest.2024.
PubMed
Germline mutations of Holliday junction resolvase genes in multiple primary
malignancies involving lung cancer lead to PARP inhibitor sensitization.
Clin Cancer Res. 2024 Feb 13. doi: 10.1158/1078-0432.CCR-22-3300.
PubMed
Abstract available
A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical
Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung
Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
Clin Lung Cancer. 2024 Jan 26:S1525-7304(24)00006.
PubMed
Abstract available
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in
Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and
Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung
Cancer Registry Data
Clin Lung Cancer. 2024 Feb 2:S1525-7304(24)00007.
PubMed
Abstract available
Safety profile of pembrolizumab monotherapy based on an aggregate safety
evaluation of 8937 patients.
Eur J Cancer. 2024;199:113530.
PubMed
Abstract available
Burden of comorbidities: Osteoporotic vertebral fracture during non-small cell
lung cancer - the BONE study.
Eur J Cancer. 2024;200:113604.
PubMed
Abstract available
Early morning immune checkpoint blockade and overall survival of patients with
metastatic cancer: An In-depth chronotherapeutic study.
Eur J Cancer. 2024;199:113571.
PubMed
Abstract available
Quantitative imaging workshop XIX: Utilizing quantitative thoracic imaging to
optimize population health final summary.
Int J Cancer. 2024;154:1365-1370.
PubMed
Abstract available
Prognostic significance of circulating tumor cells and tumor related transcripts
in small cell lung cancer: A step further to clinical implementation.
Int J Cancer. 2024 Feb 14. doi: 10.1002/ijc.34886.
PubMed
Abstract available
Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung
Cancer: Queen's Gambit or CheckMate?
Int J Radiat Oncol Biol Phys. 2024;118:585-586.
PubMed
What if Perioperative Therapy for Non-Small Cell Lung Cancer Renders Someone
Inoperable?
Int J Radiat Oncol Biol Phys. 2024;118:587.
PubMed
Pneumonitis risk after chemoradiotherapy with and without immunotherapy in
patients with locally advanced non-small cell lung cancer: A systematic review
and meta-analysis.
Int J Radiat Oncol Biol Phys. 2024 Feb 13:S0360-3016(24)00298.
PubMed
Abstract available
MAP4 acts as an oncogene and prognostic marker and affects radioresistance by
mediating epithelial-mesenchymal transition in lung adenocarcinoma.
J Cancer Res Clin Oncol. 2024;150:88.
PubMed
Abstract available
Guanylate binding protein 4 shapes an inflamed tumor microenvironment and
identifies immuno-hot tumors.
J Cancer Res Clin Oncol. 2024;150:90.
PubMed
Abstract available
Clinical characteristics of patients treated with immune checkpoint inhibitors in
EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational
registry study.
J Cancer Res Clin Oncol. 2024;150:89.
PubMed
Abstract available
Association between a network-based physician linchpin score and cancer patient
mortality: a SEER-Medicare analysis.
J Natl Cancer Inst. 2024;116:230-238.
PubMed
Abstract available
PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small
Cell Lung Cancer Treated with Curative Radiotherapy.
J Nucl Med. 2024 Feb 15:jnumed.123.266749. doi: 10.2967/jnumed.123.266749.
PubMed
Abstract available
Induction Therapy for Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2024 Feb 12:S0022-5223(24)00160.
PubMed
Discussion to: Surgical outcomes after chemotherapy plus nivolumab and
chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung
cancer.
J Thorac Cardiovasc Surg. 2024 Feb 10:S0022-5223(24)00022.
PubMed
Targeted versus systematic nodal staging in early-stage lung cancer.
J Thorac Cardiovasc Surg. 2024 Feb 8:S0022-5223(24)00004.
PubMed
Discussion to: AATS 2023: Empiric flap coverage for the pneumonectomy stump: How
protective is it? A single-institution cohort study.
J Thorac Cardiovasc Surg. 2024;167:859-860.
PubMed
Extent of surgical resection for radiologically subsolid T1N0 invasive lung
adenocarcinoma: When is a wedge resection acceptable?
J Thorac Cardiovasc Surg. 2024;167:797-809.
PubMed
Abstract available
Lung surveillance following colorectal cancer pulmonary metastasectomy:
Utilization of clinicopathologic risk factors to guide strategy.
J Thorac Cardiovasc Surg. 2024;167:814-819.
PubMed
Abstract available
Commentary: The genes stand alone: Genetic risk factors predict early pulmonary
recurrence of colorectal carcinoma metastases.
J Thorac Cardiovasc Surg. 2024;167:820-821.
PubMed
Empiric flap coverage for the pneumonectomy stump: How protective is it? A
single-institution cohort study.
J Thorac Cardiovasc Surg. 2024;167:849-858.
PubMed
Abstract available
Discussion to: Extent of surgical resection for radiologically subsolid T1N0
invasive lung adenocarcinoma: When is a wedge resection acceptable?
J Thorac Cardiovasc Surg. 2024;167:810-811.
PubMed
SCLC Classification by Platinum Sensitivity in the Era of Immunotherapy: Mere
Relic or a Valuable Treasure to Keep?
J Thorac Oncol. 2024;19:193-195.
PubMed
Partners in Crime: Co-Occurring Genetic Alterations in EGFR-Mutant NSCLC.
J Thorac Oncol. 2024;19:190-192.
PubMed
Is Real-World Evidence on Acquired Resistance to Osimertinib Relevant Clinically?
J Thorac Oncol. 2024;19:187-189.
PubMed
Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic
Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case Report.
J Thorac Oncol. 2024;19:337-343.
PubMed
Abstract available
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for
Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses from the
KEYNOTE-826 Randomized Clinical Trial.
JAMA Oncol. 2023 Dec 14. doi: 10.1001/jamaoncol.2023.5410.
PubMed
Abstract available
HLA-I levels correlate with survival outcomes in response to immune checkpoint
inhibitors in non-small cell lung cancer.
Lung Cancer. 2024;189:107502.
PubMed
Abstract available
Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer
receiving ALK-TKIs therapy.
Lung Cancer. 2024;189:107503.
PubMed
Abstract available
Canakinumab in combination with docetaxel compared with docetaxel alone for the
treatment of advanced non-small cell lung cancer following platinum-based doublet
chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized,
double-blind, phase
Lung Cancer. 2024;189:107451.
PubMed
Abstract available
A multidisciplinary review of several aspects of Asbestos-Related Lung Cancer
(ARLC).
Lung Cancer. 2024 Jan 17:107474. doi: 10.1016/j.lungcan.2024.107474.
PubMed
Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.
Lung Cancer. 2024;189:107495.
PubMed
Abstract available
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell
lung cancer: a phase 2 umbrella trial.
Nat Med. 2024 Feb 13. doi: 10.1038/s41591-024-02808.
PubMed
Abstract available
Expression of Concern: Comparison of 18F-FDG PET/CT and DWI for detection of
mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
PLoS One. 2024;19:e0299045.
PubMed
SP3-induced Timeless transcription contributes to cell growth of lung
adenocarcinoma cells.
PLoS One. 2024;19:e0298295.
PubMed
Abstract available
Lineage-specific intolerance to oncogenic drivers restricts histological
transformation.
Science. 2024;383:eadj1415.
PubMed
Abstract available
Protective effect of height on long-term survival of resectable lung cancer: a
new feature of the lung cancer paradox.
Thorax. 2024 Feb 15:thorax-2023-220443. doi: 10.1136/thorax-2023-220443.
PubMed
Abstract available
Thank you for your interest in scientific medicine.